Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
2 Reasons Hims & Hers Will Break $50s - Buy Post Earnings
01:27pm, Tuesday, 06'th May 2025
Hims & Hers Health, Inc. impressed with strong Q1 earnings, subscriber growth, and a promising partnership with Novo Nordisk, but didn't guide as well as we all hoped. The two reasons I'm buying are 1
Hims & Hers stock jumps after blowout quarter, long-term guidance stuns Street
12:06pm, Tuesday, 06'th May 2025
Shares of Hims & Hers Health (HIMS) surged 10% on Tuesday morning after the telehealth company posted first-quarter results that far surpassed Wall Street expectations and unveiled an ambitious roadma
Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)
12:05pm, Tuesday, 06'th May 2025
Live Updates Live Coverage Has Ended HIMS forward guidance is exciting 5:02 pm by Joel South HOLY MOLY $HIMS JUST GUIDED TO $6.5B IN 2030 SALES WITH 20% EBITDA MARGINS pic.twitter.com/9w2fDU8rlQ — S
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential
11:32am, Tuesday, 06'th May 2025
There are only a few companies that come around every half-decade or so that really get the gears turning in terms of having the right fundamental makeup for value investors. It just so happens that t
HIMS Earnings Rally, Guidance Powers CEG, DASH Moves Lower
10:30am, Tuesday, 06'th May 2025
Hims & Hers (HIMS) rallied this morning after earnings, reversing initial selling action following the report. Diane King Hall believes a huge jump in revenue and its Wegovy deal are behind the positi
Hims & Hers: Strong Q1 Masks Problematic Long-Term Value Proposition
10:16am, Tuesday, 06'th May 2025
Hims & Hers Health, Inc.'s Q1 2025 earnings show impressive growth, with revenues up 111% year-on-year and net income rising significantly, but HIMS shares dropped 8% pre-market. The company's success
HIMS Growth Potential, Weight-loss Drug Pipeline
09:07am, Tuesday, 06'th May 2025
Raul Shah says Hims & Hers (HIMS) latest earnings report was a win for two reasons: A lot of operating leverage and expanding growth. Raul believes HIMS guidance was "implausible" in his estimation, a
Hims & Hers Health, Inc. (HIMS) Q1 2025 Earnings Call Transcript
07:52pm, Monday, 05'th May 2025
Hims & Hers Health, Inc. (NYSE:HIMS ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Bill Newby - Head of Investor Relations Andrew Dudum - Co-Founder and Chief Executive
Here's What Key Metrics Tell Us About Hims & Hers Health (HIMS) Q1 Earnings
07:30pm, Monday, 05'th May 2025
While the top- and bottom-line numbers for Hims & Hers Health (HIMS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metric
Hims & Hers Health, Inc. (HIMS) Beats Q1 Earnings and Revenue Estimates
06:40pm, Monday, 05'th May 2025
Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.05 per share a year ago.
Hims & Hers (HIMS) Blows Out Earnings Expectations
04:53pm, Monday, 05'th May 2025
Hims & Hers Health, Inc. reported a strong financial performance for Q1 2025, with revenue reaching $586 million, marking a 111% increase year-over-year.
Hims & Hers gives weak outlook but says more collaborations are coming
04:50pm, Monday, 05'th May 2025
Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft guidance. For its second quarter, Hims & Hers said it expected to report reven
Hims & Hers Health Revenue Jumps, But Outlook Disappoints
04:50pm, Monday, 05'th May 2025
Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook missed Wall Street's expectations.
EARNINGS ALERT: HIMS
04:42pm, Monday, 05'th May 2025
While Palantir (PLTR) trading was vastly unchanged after hours , Hims & Hers (HIMS) saw some downside action following its earnings. George Tsilis notes it has "become quite profitable over the years,
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
04:05pm, Monday, 05'th May 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first
